195 related articles for article (PubMed ID: 7606790)
21. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
[TBL] [Abstract][Full Text] [Related]
22. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.
Pérez-Villar JJ; Melero I; Rodríguez A; Carretero M; Aramburu J; Sivori S; Orengo AM; Moretta A; López-Botet M
J Immunol; 1995 Jun; 154(11):5779-88. PubMed ID: 7751628
[TBL] [Abstract][Full Text] [Related]
23. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of tyrosine phosphorylation and calcium mobilization by Fc gamma receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45.
Rankin BM; Yocum SA; Mittler RS; Kiener PA
J Immunol; 1993 Jan; 150(2):605-16. PubMed ID: 8419492
[TBL] [Abstract][Full Text] [Related]
25. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking.
Hauzenberger E; Klominek J; Holgersson J
Eur J Immunol; 2004 Apr; 34(4):1154-63. PubMed ID: 15048727
[TBL] [Abstract][Full Text] [Related]
26. CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.
Starling GC; Hart DN
Immunology; 1990 Oct; 71(2):190-5. PubMed ID: 2146214
[TBL] [Abstract][Full Text] [Related]
27. Cross-linking of alpha 4 beta 1 and alpha 5 beta 1 fibronectin receptors enhances natural killer cell cytotoxic activity.
Palmieri G; Serra A; De Maria R; Gismondi A; Milella M; Piccoli M; Frati L; Santoni A
J Immunol; 1995 Dec; 155(11):5314-22. PubMed ID: 7594545
[TBL] [Abstract][Full Text] [Related]
28. Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells.
Vance BA; Huizinga TW; Wardwell K; Guyre PM
J Immunol; 1993 Dec; 151(11):6429-39. PubMed ID: 8245476
[TBL] [Abstract][Full Text] [Related]
29. Activation of natural killer cells via the Fc gamma RIII (CD16) requires initial tyrosine phosphorylation.
Ståhls A; Heiskala M; Mustelin T; Andersson LC
Eur J Immunol; 1992 Feb; 22(2):611-4. PubMed ID: 1371474
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-alpha production involving the LFA-1 integrin.
Aramburu J; Balboa MA; Rodríguez A; Melero I; Alonso M; Alonso JL; López-Botet M
J Immunol; 1993 Oct; 151(7):3420-9. PubMed ID: 8104219
[TBL] [Abstract][Full Text] [Related]
32. Receptors for the Fc fragment of IgG on natural killer cells.
Trinchieri G; Valiante N
Nat Immun; 1993; 12(4-5):218-34. PubMed ID: 8257828
[TBL] [Abstract][Full Text] [Related]
33. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.
Edberg JC; Kimberly RP
J Immunol; 1997 Oct; 159(8):3849-57. PubMed ID: 9378972
[TBL] [Abstract][Full Text] [Related]
34. Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction.
Trezzini C; Jungi TW; Spycher MO; Maly FE; Rao P
Immunology; 1990 Sep; 71(1):29-37. PubMed ID: 1698715
[TBL] [Abstract][Full Text] [Related]
35. Monomeric IgG2 enhances Ig production and proliferation in human B cells.
Kimata H; Yoshida A; Ishioka C; Jiang Y; Kusunoki T; Mikawa H
Biotechnol Ther; 1993; 4(1-2):1-16. PubMed ID: 8374507
[TBL] [Abstract][Full Text] [Related]
36. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
Uggla CK; Geisberg M; Jondal M; Knowles RW
Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
[TBL] [Abstract][Full Text] [Related]
37. Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells.
Pignata C; Prasad KV; Robertson MJ; Levine H; Rudd CE; Ritz J
J Immunol; 1993 Dec; 151(12):6794-800. PubMed ID: 8258691
[TBL] [Abstract][Full Text] [Related]
38. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
[TBL] [Abstract][Full Text] [Related]
39. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
Dall'Ozzo S; Tartas S; Paintaud G; Cartron G; Colombat P; Bardos P; Watier H; Thibault G
Cancer Res; 2004 Jul; 64(13):4664-9. PubMed ID: 15231679
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human natural killer cell activity by cytophilic immunoglobulin G.
Sulica A; Gherman M; Galatiuc C; Manciulea M; Herberman RB
J Immunol; 1982 Mar; 128(3):1031-6. PubMed ID: 7057031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
